Knockdown of CHD4 could overcome the resistance of approved drugs in acute myeloid leukemia cells or in human epidermal growth factor receptor 2-positive patients 23, 24 and also inhibit tumor growth and increase cytotoxicity in breast cancer 24-27. Here, CHD4 is linked to neoplasm.